RGNX

REGENXBIO Inc.

Biotechnology · Biotechnology

$182.64 sample

-2.66 (-1.44%) 1D

Market cap

$292.3B

Price as of

2026-10-03

Latest filing

8-K · 2026-09-02

Alerts

8

Price$182.64 -2.74% 3M daily closessample

187.78175.97

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 30INSInsider buy: 10% owner
Sep 22INSInsider buy: Chief Financial Officer
Sep 11INSInsider sell: Chief Executive Officer
Sep 02SECDEF 14A filed
Aug 26INSInsider buy: Director
Aug 18INSInsider buy: 10% owner
Aug 13SEC10-Q filed
Aug 05INSInsider sell: Chief Executive Officer

Sign up to see the real RGNX record →

Company facts

SEC EDGAR registration

Name: REGENXBIO Inc.
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: +59sample, -100 to +100
Reporting currency: USD

Who is positioning in RGNX

sample

Insiders: 24 insider transactions over 90 days, net selling, $142.1M
Congress: No member trades over 90 days
Institutions · 13F: 36 funds hold $6.1B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$12.9B +17.0% y/y

Q4 2024Q3 2026

Inventory$7.4B +15.6% y/y

Q4 2024Q3 2026

Accounts receivable$5.5B +10.4% y/y

Q4 2024Q3 2026

Total debt$14.5B +12.2% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $271.9B +7.4% 3M
Sample peer B: $103.2B +12.8% 3M
Sample peer C: $38.6B +7.7% 3M
Sample peer D: $185.6B +3.0% 3M
Sample peer E: $263.7B +14.0% 3M